These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 35398739)

  • 21. [Multifunctional ligands--a new approach in the search for drugs against multi-factorial diseases].
    Wichur T; Malawska B
    Postepy Hig Med Dosw (Online); 2015 Jan; 69():1423-34. PubMed ID: 27259214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Recent Appraisal of Small-Organic Molecules as Anti-Alzheimer's Agents.
    Gupta M; Kumar A; Ojha M; Khan SK; Nain S
    Mini Rev Med Chem; 2023; 23(8):962-976. PubMed ID: 36154572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
    Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G
    Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphing cholinesterase inhibitor amiridine into multipotent drugs for the treatment of Alzheimer's disease.
    Mezeiova E; Prchal L; Hrabinova M; Muckova L; Pulkrabkova L; Soukup O; Misiachna A; Janousek J; Fibigar J; Kucera T; Horak M; Makhaeva GF; Korabecny J
    Biomed Pharmacother; 2024 Apr; 173():116399. PubMed ID: 38492439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease.
    Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML
    Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush.
    Rosini M; Simoni E; Bartolini M; Cavalli A; Ceccarini L; Pascu N; McClymont DW; Tarozzi A; Bolognesi ML; Minarini A; Tumiatti V; Andrisano V; Mellor IR; Melchiorre C
    J Med Chem; 2008 Aug; 51(15):4381-4. PubMed ID: 18605718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
    Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
    Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromones: privileged scaffolds for the production of multi-target-directed-ligand agents for the treatment of Alzheimer's disease.
    Silva CFM; Pinto DCGA; Silva AMS
    Expert Opin Drug Discov; 2018 Dec; 13(12):1141-1151. PubMed ID: 30430870
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.
    Iraji A; Khoshneviszadeh M; Firuzi O; Khoshneviszadeh M; Edraki N
    Bioorg Chem; 2020 Apr; 97():103649. PubMed ID: 32101780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-Target Drug Design of Anti-Alzheimer's Disease based on Tacrine.
    Tian S; Huang Z; Meng Q; Liu Z
    Mini Rev Med Chem; 2021; 21(15):2039-2064. PubMed ID: 33583371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease.
    Mezeiova E; Chalupova K; Nepovimova E; Gorecki L; Prchal L; Malinak D; Kuca K; Soukup O; Korabecny J
    Curr Alzheimer Res; 2019; 16(9):772-800. PubMed ID: 30819078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease.
    Unzeta M; Esteban G; Bolea I; Fogel WA; Ramsay RR; Youdim MB; Tipton KF; Marco-Contelles J
    Front Neurosci; 2016; 10():205. PubMed ID: 27252617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).
    Mishra P; Kumar A; Panda G
    Bioorg Med Chem; 2019 Mar; 27(6):895-930. PubMed ID: 30744931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dimeric Tacrine(10)-hupyridone as a Multitarget-Directed Ligand To Treat Alzheimer's Disease.
    Xuan Z; Gu X; Yan S; Xie Y; Zhou Y; Zhang H; Jin H; Hu S; Mak MSH; Zhou D; Keung Tsim KW; Carlier PR; Han Y; Cui W
    ACS Chem Neurosci; 2021 Jul; 12(13):2462-2477. PubMed ID: 34156230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects.
    Sharma P; Singh M
    Life Sci; 2023 May; 320():121568. PubMed ID: 36925061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach.
    Kumar S; Mahajan A; Ambatwar R; Khatik GL
    Curr Med Chem; 2024; 31(37):6032-6062. PubMed ID: 37861025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-Target Directed Ligands (MTDLs): Promising Coumarin Hybrids for Alzheimer's Disease.
    Bhatia R; Chakrabarti SS; Kaur U; Parashar G; Banerjee A; Rawal RK
    Curr Alzheimer Res; 2021; 18(10):802-830. PubMed ID: 34879800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer's disease.
    Wenzel TJ; Klegeris A
    Life Sci; 2018 Aug; 207():314-322. PubMed ID: 29940242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyanobiphenyls: Novel H
    Godyń J; Zaręba P; Łażewska D; Stary D; Reiner-Link D; Frank A; Latacz G; Mogilski S; Kaleta M; Doroz-Płonka A; Lubelska A; Honkisz-Orzechowska E; Olejarz-Maciej A; Handzlik J; Stark H; Kieć-Kononowicz K; Malawska B; Bajda M
    Bioorg Chem; 2021 Sep; 114():105129. PubMed ID: 34217977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer's disease.
    Khalid S; Zahid MA; Ali H; Kim YS; Khan S
    BMC Neurosci; 2018 Nov; 19(1):74. PubMed ID: 30424732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.